The evidence supporting continuous therapy in multiple myeloma
Timing of Transplant for Multiple Myeloma
Optimal Use of Transplant for Myeloma Early-Late-nonablative Koen van Besien, MD, PhD Weill Cornell Medical College.
Evaluation de la maladie résiduelle dans les lymphomes non hodgkiniens C Tarella, Torino.
Timing of Transplant for Multiple Myeloma Robert Z. Orlowski, Ph.D., M.D. Director, Myeloma Section Professor, Departments of Lymphoma/Myeloma & Experimental.
The role of transplant for CML in the imatinib era Dr Wendy Ingram Consultant Haematologist University Hospital of Wales.
